why doesn't glp 1 work for me If you're struggling to get to a healthy weight, medications like GLP-1 receptor agonists might help. Here's how GLP-1: The Diabetes Drug Changing

Peer-reviewed studies relevant to Epithalon are listed in the Citations tab on this product page

The actual impact AOMs will have will reflect the characteristics of a life and health insurers insured portfolio

In the current paper, Nasca and her colleagues, in collaboration with Natalie Rasgon, M.D., Ph.D., at Stanford University, have published a translational study looking at the LAC levels in two non-overlapping patient populations

Common Endpoints by Route Endpoint Skin firmness or smoothness Topical timeline 8-12 weeks Injectable framing Anecdotal

A major real-world study published in early 2026 led by researchers at Johns Hopkins Bloomberg School of Public Health and analysing electronic health records from approximately 175,000 people with T1D in the US found that those taking GLP-1 drugs had a roughly 15% lower five-year risk of major cardiovascular events and a 19% lower risk of end-stage kidney disease, without any increase in hospitalisation for DKA or severe hypoglycemia

Final Verdict Kind Patches presents its product as a simpler alternative to GLP-1s, without medical involvement